# Nobel Prize in Medicine 2026 goes to the pioneers of optogenetics

URL: https://upsc.help/current-affairs/2026-10-06/nobel-medicine-2026-optogenetics/
Date: 6 October 2026 (2026-10-06)
Source: The Hindu, Page 1
UPSC papers: GS3
Publisher: upsc.help (Pratidin), free and open-source UPSC Civil Services current affairs. Not affiliated with UPSC. Every fact was checked against the source reports by a separate review before publishing.

**In one line:** Three scientists won the 2026 Nobel Prize in Physiology or Medicine for discovering light-gated ion channels in algae and turning them into optogenetics, a way to control chosen nerve cells with light.

The Nobel Assembly at Karolinska Institutet in Stockholm announced on 5 October 2026 that the Nobel Prize in Physiology or Medicine goes to Karl Deisseroth of Stanford University in the U.S., Peter Hegemann of Humboldt University of Berlin and Georg Nagel of the University of Würzburg in Germany. They were honoured for discoveries concerning light-gated ion channels and optogenetics, a technique that uses light to switch chosen nerve cells on or off. The prize of 12 million Swedish kronor is shared equally among the three. Nobel Prizes are presented on 10 December, the anniversary of Alfred Nobel's death.

The work began with a basic question: how does the single-celled green alga Chlamydomonas swim towards light? In the 1990s Hegemann's studies showed that light falling on the alga triggers electrical signals. In 2002 and 2003 Nagel, Hegemann and colleagues identified the proteins responsible, channelrhodopsin-1 and channelrhodopsin-2. A channelrhodopsin sits in the cell membrane and opens a pore when it absorbs light, letting positively charged ions flow into the cell. Nerve cells signal through exactly such ion flows, so the protein can make a neuron fire on command. In 2005 Deisseroth's group put the channelrhodopsin-2 gene into rat nerve cells and showed that flashes of blue light triggered nerve signals with millisecond precision. Deisseroth named the field optogenetics in 2006, and the method was soon extended to the brains of living animals, with light delivered through thin optical fibres.

Optogenetics changed neuroscience because it lets researchers test cause and effect. Instead of only observing that a brain region is active during a behaviour, they can switch a defined set of cells on or off and see what changes. Related light-driven proteins such as halorhodopsin silence neurons, so cells can be both activated and inhibited. The method has been used to map circuits for pain, sleep, memory, attention, fear, reward and social behaviour, and to study depression, Parkinson's disease and Alzheimer's disease. It is still mainly a research tool. Its clearest human result so far is in the eye: in 2021 researchers reported partial recovery of visual function in a blind patient with retinitis pigmentosa after optogenetic therapy. Wider human use needs safe delivery of the gene to the right cells and a way to get light to them.

## Prelims facts

- The 2026 Nobel Prize in Physiology or Medicine (announced 5 October 2026) went to Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries concerning light-gated ion channels and optogenetics.
- Channelrhodopsins come from the green alga Chlamydomonas; channelrhodopsin-2 opens an ion channel for positively charged ions when it absorbs blue light.
- Deisseroth's group first used channelrhodopsin-2 to fire rat neurons with light in 2005, and he named the field optogenetics in 2006.
- Optogenetics can both activate neurons (channelrhodopsin) and silence them (halorhodopsin), giving cell-type and millisecond precision.
- The prize is 12 million Swedish kronor, shared equally; in 2021 a blind retinitis pigmentosa patient partially recovered vision after optogenetic therapy.

## Quick recall

- **Who won the 2026 Nobel Prize in Physiology or Medicine?** Karl Deisseroth, Peter Hegemann and Georg Nagel, for discoveries concerning light-gated ion channels and optogenetics.
- **What is optogenetics?** A technique that uses light-sensitive proteins, introduced by genetic modification, to switch chosen cells, usually neurons, on or off with light.
- **From which organism were channelrhodopsins first identified?** The single-celled green alga Chlamydomonas reinhardtii.
- **What colour of light opens channelrhodopsin-2?** Blue light.
- **Which protein is used to silence neurons in optogenetics?** Halorhodopsin, a light-driven ion pump.
- **When did Deisseroth's group first fire mammalian neurons with channelrhodopsin-2?** 2005, in rat neurons; the field was named optogenetics in 2006.
- **What is the 2026 Nobel prize amount?** 12 million Swedish kronor, shared equally among the three laureates.
- **Which disease saw the first reported partial vision recovery after optogenetic therapy?** Retinitis pigmentosa, in a blind patient, reported in 2021.

## Prelims practice question

With reference to optogenetics, consider the following statements:
1. It uses light-sensitive proteins, introduced into specific cells by genetic modification, to control the activity of those cells.
2. Channelrhodopsins used in optogenetics were first identified in bacteria living in hot springs.
3. The technique can be used both to activate and to silence neurons.
Which of the statements given above are correct?

(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3

Answer: (c) 1 and 3 only. Statement 1 is correct: the gene for a light-sensitive protein is put into chosen cells, which then respond to light. Statement 2 is wrong: channelrhodopsin-1 and -2 were identified in the green alga Chlamydomonas, not in hot-spring bacteria. Statement 3 is correct: channelrhodopsin activates neurons, while halorhodopsin, a light-driven pump, silences them.

## UPSC previous-year questions this connects to

- UPSC Mains 2014, GS3: Scientific research in Indian universities is declining, because a career in science is not as attractive as business professions, engineering or administration, and the universities are becoming consumer-oriented. Critically comment. (https://upsc.help/pyq/q239-scientific-research-indian-universities-declining-because-career/)
  How to use this story in the answer: Use the 2026 Nobel to show that university-based basic research yields transformative tools, strengthening the case for reviving research careers in Indian universities.
- UPSC Mains 2025, GS3: How can India achieve energy independence through clean technology by 2047? How can biotechnology play a crucial role in this endeavour? (https://upsc.help/pyq/q063-can-india-achieve-energy-independence-through-clean/)

## Mains practice question

The 2026 Nobel Prize in Physiology or Medicine for optogenetics shows how curiosity-driven basic research can create transformative technologies. Discuss with reference to its applications and limitations. (150 words)

### Model answer

The 2026 Nobel Prize in Physiology or Medicine went to Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries concerning light-gated ion channels and optogenetics, the use of light to control chosen nerve cells.

## From basic question to tool
- Hegemann and Nagel studied how the alga Chlamydomonas senses light and, in 2002 and 2003, identified channelrhodopsin-1 and -2.
- In 2005 Deisseroth's group put channelrhodopsin-2 into rat neurons and fired them with blue light; the field was named in 2006.
- No one set out to build a brain tool: it grew from research on algae.

## Applications
- Tests cause and effect in brain circuits for pain, sleep, memory, fear and reward.
- Research on depression, Parkinson's and Alzheimer's disease.
- 2021: partial recovery of vision in a blind retinitis pigmentosa patient.

## Limitations
- Needs genetic modification of human cells and light delivery into tissue.
- Still largely confined to laboratories.

## Lesson for India
- Patient funding of basic science, not only mission-mode projects, builds future capability.

Optogenetics is a reminder that fundamental curiosity often yields the most useful technology.

## The basics

## Why this matters

The brain has tens of billions of nerve cells of many different types packed together. For a century scientists could record their activity or stimulate whole regions, but they could not switch one type of cell on or off at will and watch the result. Optogenetics, honoured with the 2026 Nobel Prize in Physiology or Medicine, made that possible. For UPSC it shows how basic research becomes a tool.

## The basic idea

A nerve cell carries a small electrical charge across its membrane. When enough positively charged ions rush in through channels in the membrane, the cell fires a signal. A Channelrhodopsin is a channel that opens when it absorbs light. Put its gene into a chosen type of neuron, shine light on it, and only those neurons fire. This builds on the ordinary physiology of Ion channels and the nerve impulse.

## From algae to neurons

The story began with a question about how the alga Chlamydomonas senses light, not with neuroscience.

## Why it beat older methods

## Where it stands now

Optogenetics is used worldwide to map circuits for pain, sleep, memory, fear and reward. In people its first clear result came in the eye, where light can reach the retina easily: see Optogenetics in medicine. Gene delivery and light delivery deep in the body remain the hurdles. The prize itself has a long history, described in The Nobel Prize in Physiology or Medicine.

## Sources

- https://www.aljazeera.com/news/2026/10/5/nobel-medicine-prize-honours-us-and-german-scientists-for-optogenetics-work
- https://www.statnews.com/2026/10/05/nobel-prize-medicine-2026-winner-deisseroth-hegemann-nagel/
- https://english.news.cn/europe/20261006/fe051d42f7e14e2cb2000f3d562f5824/c.html
- https://en.wikipedia.org/wiki/Optogenetics
- https://en.wikipedia.org/wiki/Channelrhodopsin
- https://superkalam.com/current-affairs/06-10-2026/trio-wins-medicine-nobel-for-controlling-neurons-with-light-pg1-69f66949-e345-445f-bba9-0a544be5867f
